FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/10/028659 [Registered on: 27/10/2020] Trial Registered Prospectively
Last Modified On: 20/10/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study Of Efficacy Of Punarnavashtaka Kwatha In The Management of Anaemia. 
Scientific Title of Study   Randomised Control Clinical Study Of Efficacy Of Punarnavashtaka Kwatha In The Management of Kaphaj Pandu. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vd Deepak Deochand Bhoyar 
Designation  PG Scholar 
Affiliation  Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya 
Address  Department Of Kayachikitsa, Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya, Vishwashanti dham, Kesnand road, Wagholi, Pune-412207
Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya, Vishwashanti dham, Kesnand road, Wagholi, Pune-412207
Pune
MAHARASHTRA
412207
India 
Phone  7875861261  
Fax    
Email  drdeep.bhoyar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Anjali A Deshpande 
Designation  Professor & HOD of Kayachikitsa 
Affiliation  Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya 
Address  Department Of Kayachikitsa, Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya, Vishwashanti dham, Kesnand road, Wagholi, Pune-412207
Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya, Vishwashanti dham, Kesnand road, Wagholi, Pune-412207
Pune
MAHARASHTRA
412207
India 
Phone  9730069747  
Fax    
Email  anjalidesh1610@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vd Anjali A Deshpande 
Designation  Professor & HOD of Kayachikitsa 
Affiliation  Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya 
Address  Department Of Kayachikitsa, Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya, Vishwashanti dham, Kesnand road, Wagholi, Pune-412207
Bharatiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya, Vishwashanti dham, Kesnand road, Wagholi, Pune-412207

MAHARASHTRA
412207
India 
Phone  9730069747  
Fax    
Email  anjalidesh1610@gmail.com  
 
Source of Monetary or Material Support  
Bharatiya Sanskriti Darshan Trusts Ayurved Hospital & Research Center, Vishwashanti Dham, Kesnand Road, Wagholi, Pune-412207 
 
Primary Sponsor  
Name  BSDTs Ayurved Hospital Research Center Wagholi Pune 
Address  BSDTs Ayurved Hospital & Research Center, Vishwashanti Dham, Kesnand Road, Wagholi, Pune-412207 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vd Deepak Deochand Bhoyar  Bharatiya Sanskriti Darshan Trusts Ayurved Hospital & Research Center, Wagholi, Pune  OPD No.1, department of Kayachikitsa, Bharatiya Sanskriti Darshan Trusts Ayurved Hospital & Research Center, Vishwashanti Dham, Kesnand Road, Wagholi, Pune-412207
Pune
MAHARASHTRA 
7875861261

drdeep.bhoyar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D758||Other specified diseases of bloodand blood-forming organs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A-Punarnavashtaka Kwatha  Group A-Punarnavashtaka Kwatha 40ml in Vyanodaan kala orally for 28 days will be given to 32 patients diagnosed with Kaphaj Pandu with assessment on 0th, 15th, 29th day. 
Comparator Agent  Group B-Navayasa Loha Vati  Group B-Navayasa Loha Vati 500mg in Vyanodaan kala along with koshna jala will be given orally for 28 days to 32 patients diagnosed with Kaphaj Pandu .Assessment will be done on 0th, 15th, 29th day. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  (1) Patient having signs and symptoms of Kaphaj Pandu (Panduta, Akshikootshoth, Hridspandan, Gauravta, Chardi) more than 1 to 2 months.
(2) Hb % of either gender between 7-11gm/dl will be selected.  
 
ExclusionCriteria 
Details  Mrudbhakshanjanya Pandu
Garbhinijanya Pandu
Sannipataka Pandu
K/c/o Aplastic Anaemia, Sickle cell Anaemia like disorder.
Patient with severe systemic disorders and surgical illnesses.
Patient with Haemorrhagic disorders.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
(1) To Observe and document the effect of Punarnavashtaka kwatha in the management of Kaphaj Pandu.
(2) To Observe and document the effect of Punarvashtaka kwatha in Signs and symptoms of Kaphaj Pandu.
 
0th, 15th, 29th day 
 
Secondary Outcome  
Outcome  TimePoints 
(1) To find out the adverse effect of Punarnavashtaka Kwatha if any.
(2) To assess the effect of Punarnavashtaka Kwatha by Biochemical investigation. 
0th, 29th day 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/10/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   not yet done 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary        The current study is a randomised control parallel group trial comparing the efficacy of Punarnavashtaka Kwatha 40 ml in Vyanodaan kala with Navayas Loha Vati 500 mg in Vyanodaan kala for 28 days duration. Each group comprising of 32 patients diagnosed as Kaphaj Pandu. Assessment will be done on the 0th, 15th, 29th day. 
     Considering the increased flow of patients coming to the OPD with complaints of Gauravta, Chhardi, Prasek, Bhram, Klama, Aruchi, Alasya etc this study has been selected. Santarpanjanya hetu like Junk food, Paryushit anna, Atyambupan, Guru ahara, Sedentary lifestyle, Mental stress, etc mentioned by our Ayurved classics are relevant even in todays era. 
     Punarnavashtak Kwatha a simple formulation has been described in the Ayurvedic text of Bhaishajya Ratnavali- Shotha roga chikitsa prakaran, 42/13. This kalpa mainly consists of ingredients which acts as Kaphaghna, Pittashamak, Raktavardhak, Deepana, Pachana, Yakrutottejak and Krumighna thus helping to break the samprapti of Pandu. Punarnavashtak Kwath being easily available, easily palatable, so I have selected this drug for this study.
 
Close